Lynx1 Capital Management LP Gh Research PLC Transaction History
Lynx1 Capital Management LP
- $338 Million
- Q2 2025
A detailed history of Lynx1 Capital Management LP transactions in Gh Research PLC stock. As of the latest transaction made, Lynx1 Capital Management LP holds 6,746,951 shares of GHRS stock, worth $81.9 Million. This represents 24.35% of its overall portfolio holdings.
Number of Shares
6,746,951
Previous 6,443,940
4.7%
Holding current value
$81.9 Million
Previous $71.1 Million
15.71%
% of portfolio
24.35%
Previous 26.28%
Shares
9 transactions
Others Institutions Holding GHRS
# of Institutions
39Shares Held
38.5MCall Options Held
0Put Options Held
2.6K-
Bvf Inc San Francisco, CA8.83MShares$107 Million4.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.68MShares$93.2 Million2.05% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$67.3 Million1.04% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$24.4 Million2.47% of portfolio
-
Deep Track Capital, LP Greenwich, CT2MShares$24.3 Million0.86% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $632M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...